Levocetirizine: The allergist's arsenal grows larger

R. Matthew Bloebaum, J. Andrew Grant

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Antihistamines are the cornerstone of treatment for many allergic diseases, such as allergic rhinitis and chronic urticaria. Since the discovery of their beneficial effects in the 1940s, scientists have found molecules with greater selectivity to block specific histamine receptors without some of the detrimental side effects that are seen if antihistamines cross the blood-brain barrier. Levocetirizine is the active enantiomer of cetirizine and a sective H1-histamine blocker. It exhibits many favourable characteristics of an ideal antihistamine, both pharmacodynamically and pharmacokinetically, including high bioavailability, rapid onset of action, limited distribution and low degree of metabolism. Furthermore, clinical trials indicate that it is safe and effective for the treatment of allergic rhinitis and chronic urticaria with a minimal amount of untoward effects. 2004

Original languageEnglish (US)
Pages (from-to)1581-1588
Number of pages8
JournalExpert Opinion on Pharmacotherapy
Volume5
Issue number7
DOIs
StatePublished - Jul 2004

Fingerprint

Histamine Antagonists
Urticaria
Cetirizine
Histamine H1 Antagonists
Histamine Receptors
Blood-Brain Barrier
Biological Availability
Clinical Trials
Therapeutics
levocetirizine
Allergists
Allergic Rhinitis

Keywords

  • Allergic rhinitis
  • Antihistamine
  • Levocetirizine
  • Urticaria

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Levocetirizine : The allergist's arsenal grows larger. / Bloebaum, R. Matthew; Grant, J. Andrew.

In: Expert Opinion on Pharmacotherapy, Vol. 5, No. 7, 07.2004, p. 1581-1588.

Research output: Contribution to journalArticle

Bloebaum, R. Matthew ; Grant, J. Andrew. / Levocetirizine : The allergist's arsenal grows larger. In: Expert Opinion on Pharmacotherapy. 2004 ; Vol. 5, No. 7. pp. 1581-1588.
@article{0f33d06d00f741a49361f46ef6ee24a0,
title = "Levocetirizine: The allergist's arsenal grows larger",
abstract = "Antihistamines are the cornerstone of treatment for many allergic diseases, such as allergic rhinitis and chronic urticaria. Since the discovery of their beneficial effects in the 1940s, scientists have found molecules with greater selectivity to block specific histamine receptors without some of the detrimental side effects that are seen if antihistamines cross the blood-brain barrier. Levocetirizine is the active enantiomer of cetirizine and a sective H1-histamine blocker. It exhibits many favourable characteristics of an ideal antihistamine, both pharmacodynamically and pharmacokinetically, including high bioavailability, rapid onset of action, limited distribution and low degree of metabolism. Furthermore, clinical trials indicate that it is safe and effective for the treatment of allergic rhinitis and chronic urticaria with a minimal amount of untoward effects. 2004",
keywords = "Allergic rhinitis, Antihistamine, Levocetirizine, Urticaria",
author = "Bloebaum, {R. Matthew} and Grant, {J. Andrew}",
year = "2004",
month = "7",
doi = "10.1517/14656566.5.7.1581",
language = "English (US)",
volume = "5",
pages = "1581--1588",
journal = "Expert Opinion on Pharmacotherapy",
issn = "1465-6566",
publisher = "Informa Healthcare",
number = "7",

}

TY - JOUR

T1 - Levocetirizine

T2 - The allergist's arsenal grows larger

AU - Bloebaum, R. Matthew

AU - Grant, J. Andrew

PY - 2004/7

Y1 - 2004/7

N2 - Antihistamines are the cornerstone of treatment for many allergic diseases, such as allergic rhinitis and chronic urticaria. Since the discovery of their beneficial effects in the 1940s, scientists have found molecules with greater selectivity to block specific histamine receptors without some of the detrimental side effects that are seen if antihistamines cross the blood-brain barrier. Levocetirizine is the active enantiomer of cetirizine and a sective H1-histamine blocker. It exhibits many favourable characteristics of an ideal antihistamine, both pharmacodynamically and pharmacokinetically, including high bioavailability, rapid onset of action, limited distribution and low degree of metabolism. Furthermore, clinical trials indicate that it is safe and effective for the treatment of allergic rhinitis and chronic urticaria with a minimal amount of untoward effects. 2004

AB - Antihistamines are the cornerstone of treatment for many allergic diseases, such as allergic rhinitis and chronic urticaria. Since the discovery of their beneficial effects in the 1940s, scientists have found molecules with greater selectivity to block specific histamine receptors without some of the detrimental side effects that are seen if antihistamines cross the blood-brain barrier. Levocetirizine is the active enantiomer of cetirizine and a sective H1-histamine blocker. It exhibits many favourable characteristics of an ideal antihistamine, both pharmacodynamically and pharmacokinetically, including high bioavailability, rapid onset of action, limited distribution and low degree of metabolism. Furthermore, clinical trials indicate that it is safe and effective for the treatment of allergic rhinitis and chronic urticaria with a minimal amount of untoward effects. 2004

KW - Allergic rhinitis

KW - Antihistamine

KW - Levocetirizine

KW - Urticaria

UR - http://www.scopus.com/inward/record.url?scp=3543088107&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3543088107&partnerID=8YFLogxK

U2 - 10.1517/14656566.5.7.1581

DO - 10.1517/14656566.5.7.1581

M3 - Article

C2 - 15212608

AN - SCOPUS:3543088107

VL - 5

SP - 1581

EP - 1588

JO - Expert Opinion on Pharmacotherapy

JF - Expert Opinion on Pharmacotherapy

SN - 1465-6566

IS - 7

ER -